SCHEMBL4325848

SCHEMBL4325848

CCCCCCCCCC(=O)OCCCN(C)C

nearest known ligand 0.83

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
DNM1 Q05193 4/20 0.83
DGKA P23743 1/20 0.69
NAAA Q02083 1/20 0.58
PRSS1 P07477 1/20 0.54
PRSS2 P07478 1/20 0.54
PRSS3 P35030 1/20 0.54
PAM P19021 2/20 0.53
HTR2C P28335 1/20 0.51
TSHR P16473 1/20 0.50
MAPT P10636 1/20 0.50
ALDH1A1 P00352 1/20 0.49
LMNA P02545 1/20 0.49
KDM4E B2RXH2 1/20 0.47
DUSP3 P51452 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8396453 1.00 DNM1 (0.83) DNM1DGKANAAAPRSS1PRSS2
SCHEMBL10622058 1.00 DNM1 (0.83) DNM1DGKANAAAPRSS1PRSS2
SCHEMBL8397697 1.00 DNM1 (0.83) DNM1DGKANAAAPRSS1PRSS2
SCHEMBL8398143 1.00 DNM1 (0.83) DNM1DGKANAAAPRSS1PRSS2
SCHEMBL6849042 1.00 DNM1 (0.83) DNM1DGKANAAAPRSS1PRSS2
SCHEMBL4322849 1.00 DNM1 (0.83) DNM1DGKANAAAPRSS1PRSS2
SCHEMBL8394705 1.00 DNM1 (0.83) DNM1DGKANAAAPRSS1PRSS2
SCHEMBL13923753 1.00 DNM1 (0.83) DNM1DGKANAAAPRSS1PRSS2
SCHEMBL8397714 1.00 DNM1 (0.83) DNM1DGKANAAAPRSS1PRSS2
SCHEMBL1074804 0.98 DNM1 (0.80) DNM1DGKANAAAPRSS1PRSS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7632869-B2 Antimicrobial compositions and uses thereof BAUSCH & LOMB INCORPORATED (US) 2009-12-15 US claimed
EP-1748798-A1 ANTIMICROBIAL COMPOSITIONS AND USES THEREOF BAUSCH & LOMB INCORPORATED (US) 2007-02-07 EP claimed
WO-2005115485-A1 ANTIMICROBIAL COMPOSITIONS AND USES THEREOF BAUSCH & LOMB INCORPORATED (US) 2005-12-08 WO claimed
US-20050260099-A1 Antimicrobial compositions and uses thereof BAUSCH & LOMB MEXICO, S.A. DE C.V. (MX) 2005-11-24 US claimed
US-7632869-B2 Antimicrobial compositions and uses thereof BAUSCH & LOMB INCORPORATED (US) 2009-12-15 US disclosed
EP-1748798-A1 ANTIMICROBIAL COMPOSITIONS AND USES THEREOF BAUSCH & LOMB INCORPORATED (US) 2007-02-07 EP disclosed
WO-2005115485-A1 ANTIMICROBIAL COMPOSITIONS AND USES THEREOF BAUSCH & LOMB INCORPORATED (US) 2005-12-08 WO disclosed
US-20050260099-A1 Antimicrobial compositions and uses thereof BAUSCH & LOMB MEXICO, S.A. DE C.V. (MX) 2005-11-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050260099-A1 Antimicrobial compositions and uses thereof GSDMD, PHOSPHO1, MLEC DNM1 260/4885DGKA 1231/4885NAAA 43/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.